Glaxo (GSK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...

The court directed the firm to pay Ms Gichuki 10 months’ salary as compensation would be adequate in the circumstances ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...

GSK reported core earnings of 59 cents per American ... digit percentage from prior expectation of being stable. Currently, Glaxo has an average Growth Score of C, a grade with the same score ...

GSK (GlaxoSmithKline) is due to close its Ulverston factory in June, bringing to an end 75 years of history, and we’re remembering what the pharmaceutical giant has meant to the town and the ...

The U.S. Food and Drug Administration (FDA) has accepted GlaxoSmithKlines (NYSE:GSK) biologics license application for ...

Investing.com -- The US Food and Drug Administration has accepted GlaxoSmithKline (NYSE: GSK )’s biologics license ...

Feb 13 (Reuters) - India's GlaxoSmithKline Pharmaceuticals ... The Indian unit of British drugmaker GSK (GSK.L), opens new tab said its profit before exceptional items and tax jumped 35% to ...